|1.||Jung, Timothy: 2 articles (04/2010 - 09/2006)|
|2.||Pudrith, Charles: 1 article (04/2010)|
|3.||Kim, Biblia: 1 article (04/2010)|
|4.||Jahng, Patrick: 1 article (04/2010)|
|5.||Kim, You Hyun: 1 article (04/2010)|
|6.||Wall, Michael: 1 article (04/2010)|
|7.||Martin, Dusan: 1 article (04/2010)|
|8.||Vico-Ruiz, E: 1 article (06/2009)|
|9.||Benítez-Del-Castillo-Sánchez, J M: 1 article (06/2009)|
|10.||Cuiña-Sardiña, R: 1 article (06/2009)|
01/01/1998 - "In addition, the percentage of patients with no anterior chamber inflammation was significantly higher with Rimexolone 1% than with the placebo at each assessment. "
01/01/1998 - "Rimexolone 1% markedly decreased the mean inflammation severity scores, and the sum of clinical assessments of cells and flare in the anterior chamber compared with placebo at each assessment. "
01/01/1998 - "The effects of Rimexolone 1% in postoperative inflammation after cataract extraction. "
06/01/1997 - "Rimexolone 1% ophthalmic suspension was safe and significantly more effective than a placebo in controlling intraocular inflammation after cataract extraction when used four times daily and continued for 2 weeks."
06/01/1997 - "To assess the efficacy and safety of rimexolone 1% ophthalmic suspension in controlling intraocular inflammation after cataract extraction. "
01/01/1998 - "The results suggest that Rimexolone 1% ophthalmic solution is an effective and safe steroidal anti-inflammatory agent for topical use following cataract surgery and intra-ocular lens implantation."
06/01/2009 - "To compare the efficiency and secondary effects of using 1% rimexolone or 0.1% dexamethasone as postoperative treatment for cataract surgery. "
08/01/2008 - "Rimexolone 1% ophthalmic suspension was as effective and safe as prednisolone acetate 1% ophthalmic suspension in controlling inflammation in the early period after cataract surgery."
08/01/2001 - "To compare the efficacy of a topical nonsteroidal anti-inflammatory agent (ketorolac tromethamine 0.5%) with that of a topical steroid (rimexolone 1%) to control inflammation after cataract surgery. "
08/01/2008 - "Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery."
05/01/2004 - "Rimexolone 1% ophthalmic suspension is as effective as and safer than prednisolone acetate 1% ophthalmic suspension in the treatment of anterior uveitis."
05/01/2004 - "Rimexolone is as effective as prednisolone acetate ophthalmic suspension in the treatment of anterior uveitis. "
05/01/2004 - "Efficacy and safety of 1% rimexolone versus 1% prednisolone acetate in the treatment of anterior uveitis--a randomized triple masked study."
09/01/2005 - "To compare the efficacy and safety of prednisolone acetate 1% vs. rimexolone 1% ophthalmic suspension in the treatment of acute anterior uveitis (AAU) in HLA-B27+ patients. "
05/01/2004 - "To evaluate the efficacy and safety of 1% rimexolone versus 1% prednisolone acetate ophthalmic suspension in the treatment of anterior uveitis. "
08/01/1996 - "Rimexolone 1% ophthalmic suspension is safe and effective for the treatment of uveitis."
08/01/1996 - "Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis."
10/01/1999 - "Rimexolone is a potent anti-inflammatory corticosteroid with a lower potential for elevating intraocular pressure, relative to other ophthalmic steroids, and is indicated for postsurgical inflammation and uveitis. "
|5.||Otitis Media with Effusion
09/01/2006 - "Both 1% rimexolone and 1% dexamethasone are effective in reducing the volume of middle ear effusion and mucosal thickness compared with control groups. "
09/01/2006 - "Effect of topical dexamethasone versus rimexolone on middle ear inflammation in experimental otitis media with effusion."
04/01/2010 - "This experiment was designed to determine whether glucocorticoids, dexamethasone, fluticasone propionate, or rimexolone, can reduce the concentration of NO in middle ear effusion (MEE). "
|3.||Ketorolac Tromethamine (Acular)
|4.||HLA-B27 Antigen (HLA B27 Antigen)
|3.||Intraocular Lens Implantation